Clinical trials recruiting for Relapsing-remitting Multiple Sclerosis (RRMS)
Phase breakdown
Drugs and treatments being studied
Self-screener
Recruiting trials
- A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis
- A Study of Rocbrutinib in PRL-Positive Relapsing-Remitting Multiple Sclerosis
- A Study of the Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple Sclerosis
- ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS
- Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis
- Indole-3-PROpionic Acid Clinical Trials - Multiple Sclerosis
Related conditions
Trials recruiting for Relapsing-remitting Multiple Sclerosis (RRMS) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Relapsing-remitting Multiple Sclerosis (RRMS) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.